Somatuline Autogel To Be Promoted By Tercica
This article was originally published in The Pink Sheet Daily
Executive Summary
Tercica gains the rights to the acromegaly treatment in the U.S. and Canada through a cross-licensing agreement with Ipsen, which receives European rights to Increlex.